triamcinolone acetonide

Generic: triamcinolone acetonide

Labeler: padagis israel pharmaceuticals ltd
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name triamcinolone acetonide
Generic Name triamcinolone acetonide
Labeler padagis israel pharmaceuticals ltd
Dosage Form OINTMENT
Routes
TOPICAL
Active Ingredients

triamcinolone acetonide .5 mg/g

Manufacturer
Padagis Israel Pharmaceuticals Ltd

Identifiers & Regulatory

Product NDC 45802-817
Product ID 45802-817_a43dca71-a425-4ce0-a84d-d2586b77a978
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212460
Listing Expiration 2026-12-31
Marketing Start 2021-03-01

Pharmacologic Class

Established (EPC)
corticosteroid [epc]
Mechanism of Action
corticosteroid hormone receptor agonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 45802817
Hyphenated Format 45802-817

Supplemental Identifiers

RxCUI
1090641
UPC
0345802817013
UNII
F446C597KA
NUI
N0000175576 N0000175450

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name triamcinolone acetonide (source: ndc)
Generic Name triamcinolone acetonide (source: ndc)
Application Number ANDA212460 (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • .5 mg/g
source: ndc
Packaging
  • 430 g in 1 JAR (45802-817-01)
source: ndc

Packages (1)

Ingredients (1)

triamcinolone acetonide (.5 mg/g)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "a43dca71-a425-4ce0-a84d-d2586b77a978", "openfda": {"nui": ["N0000175576", "N0000175450"], "upc": ["0345802817013"], "unii": ["F446C597KA"], "rxcui": ["1090641"], "spl_set_id": ["3cb47c24-b7eb-4709-8a41-cbeceadbc8d9"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "430 g in 1 JAR (45802-817-01)", "package_ndc": "45802-817-01", "marketing_start_date": "20210301"}], "brand_name": "triamcinolone acetonide", "product_id": "45802-817_a43dca71-a425-4ce0-a84d-d2586b77a978", "dosage_form": "OINTMENT", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]"], "product_ndc": "45802-817", "generic_name": "triamcinolone acetonide", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "triamcinolone acetonide", "active_ingredients": [{"name": "TRIAMCINOLONE ACETONIDE", "strength": ".5 mg/g"}], "application_number": "ANDA212460", "marketing_category": "ANDA", "marketing_start_date": "20210301", "listing_expiration_date": "20261231"}